World

Recent reports from Bloomberg have shed light on the possibility that the United States may take further steps to limit China’s access to crucial chip technology essential for the advancement of artificial intelligence. The Biden administration is said to be contemplating actions that would specifically target the high-tech chip architecture known as gate all-around (GAA).
0 Comments
Singapore has been identified by the World Gold Council as the next leading gold hub as the market shifts towards the east. The increase in gold consumption in major emerging economies, particularly in Asia, is a key factor driving this shift. Shaokai Fan, head of Asia-Pacific and global head of central banks, emphasized the importance
0 Comments
Norway’s $1.7 trillion sovereign wealth fund has taken a bold stand against ratifying Tesla CEO Elon Musk’s $56 billion pay package. Despite being Tesla’s eighth-biggest shareholder, the fund has decided to vote against the controversial compensation plan, which was previously invalidated by a Delaware judge earlier this year. The fund’s operator, Norges Bank Investment Management
0 Comments
In May, the U.S. economy surprised analysts by adding 272,000 jobs, significantly exceeding the expected 190,000 jobs. This unexpected increase is a positive sign for the labor market and indicates a potential slowdown in the Federal Reserve’s plans to lower interest rates. However, despite this positive news, the unemployment rate rose to 4%, the first
0 Comments
While the saying “A diamond is forever” has long been associated with the timeless allure of diamonds, it seems that consumers are now shifting their preferences towards lab-grown alternatives, gold, and colored gemstones. The once powerful diamond giant, De Beers, is facing challenges as the demand for diamonds declines in key markets such as China.
0 Comments
In a recent ruling by a U.S. court, the legal battle surrounding the discontinued heartburn drug Zantac has taken a drastic turn. The decision allows scientific evidence to be presented in over 75,000 lawsuits alleging that the once-popular drug ranitidine, known as Zantac in the U.S., may cause cancer. This ruling has sent shockwaves through
0 Comments